Bristol-Myers Squibb (BMY) stock forecast for 2025

The forecast has been updated: December 1, 2021 5:52


Bristol-Myers stock price online today

Analyst Target Price

72.84

Dividend Date

01.11.2021

Ex Dividend Date

30.09.2021

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Bristol-Myers stock stock today? What is the projected target price level for 2025? How much will it cost in 2025? Bristol-Myers stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2025.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $72.84 target price for Bristol-Myers stock stock.

Today 200 Day Moving Average is the resistance level (63.4 $).

50 Day Moving Average is the support level (58.56 $).




BMY Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 58.04 56.06 59.80 6.25 %
Feb 56.77 54.71 58.95 7.20 %
Mar 58.17 55.77 59.36 6.04 %
Apr 57.82 57.09 58.90 3.08 %
May 55.21 52.93 57.55 8.02 %
Jun 55.09 54.45 56.91 4.31 %
Jul 56.39 54.75 58.29 6.07 %
Aug 58.19 55.63 59.22 6.05 %
Sep 60.91 58.60 62.09 5.61 %
Oct 60.64 58.04 61.55 5.69 %
Nov 61.85 61.06 64.29 5.03 %
Dec 61.71 60.25 63.34 4.88 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Bristol-Myers stock.


Bristol-Myers overview

Bristol-Myers Address

430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US

Market Capitalization

121 281 135 000 $

EBITDA

19 712 000 000

PE Ratio

None

PEG Ratio

10.87

Dividend Per Share

1.96

Dividend Yield

0.0347

EPS

-2.42

Quarterly Earnings Growth YOY

-0.159

Quarterly Revenue Growth YOY

0.103

Trailing PE

-

Forward PE

7.07

EV To Revenue

3.42

EV To EBITDA

19.55

52 Week High

69.19

52 Week Low

53.23

50 Day Moving Average

58.56

200 Day Moving Average

63.4

Shares Outstanding

2219640000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Bristol-Myers stock forecast for this year


Bristol-Myers stock forecast for Jan 2025.
Estimated Average Forecasted Bristol-Myers Price: 58.04. Negative monthly dynamics of the instrument is expected with 6.246% volatility is expected.

Pessimistic forecast: 56.06

Optimistic: 59.80


Bristol-Myers stock forecast for Feb 2025.
Estimated Average Forecasted Bristol-Myers Price: 56.77. Negative monthly dynamics of the instrument is expected with 7.203% volatility is expected.

Pessimistic forecast: 54.71

Optimistic: 58.95


Bristol-Myers stock forecast for Mar 2025.
Estimated Average Forecasted Bristol-Myers Price: 58.17. Positive monthly dynamics of the instrument is expected with 6.037% volatility is expected.

Pessimistic forecast: 55.77

Optimistic: 59.36


Bristol-Myers stock forecast for Apr 2025.
Estimated Average Forecasted Bristol-Myers Price: 57.82. Negative monthly dynamics of the instrument is expected with 3.077% volatility is expected.

Pessimistic forecast: 57.09

Optimistic: 58.90


Bristol-Myers stock forecast for May 2025.
Estimated Average Forecasted Bristol-Myers Price: 55.21. Negative monthly dynamics of the instrument is expected with 8.020% volatility is expected.

Pessimistic forecast: 52.93

Optimistic: 57.55


Bristol-Myers stock forecast for Jun 2025.
Estimated Average Forecasted Bristol-Myers Price: 55.09. Negative monthly dynamics of the instrument is expected with 4.313% volatility is expected.

Pessimistic forecast: 54.45

Optimistic: 56.91


Bristol-Myers stock forecast for Jul 2025.
Estimated Average Forecasted Bristol-Myers Price: 56.39. Positive monthly dynamics of the instrument is expected with 6.067% volatility is expected.

Pessimistic forecast: 54.75

Optimistic: 58.29


Bristol-Myers stock forecast for Aug 2025.
Estimated Average Forecasted Bristol-Myers Price: 58.19. Positive monthly dynamics of the instrument is expected with 6.054% volatility is expected.

Pessimistic forecast: 55.63

Optimistic: 59.22


Bristol-Myers stock forecast for Sep 2025.
Estimated Average Forecasted Bristol-Myers Price: 60.91. Positive monthly dynamics of the instrument is expected with 5.612% volatility is expected.

Pessimistic forecast: 58.60

Optimistic: 62.09


Bristol-Myers stock forecast for Oct 2025.
Estimated Average Forecasted Bristol-Myers Price: 60.64. Negative monthly dynamics of the instrument is expected with 5.691% volatility is expected.

Pessimistic forecast: 58.04

Optimistic: 61.55


Bristol-Myers stock forecast for Nov 2025.
Estimated Average Forecasted Bristol-Myers Price: 61.85. Positive monthly dynamics of the instrument is expected with 5.026% volatility is expected.

Pessimistic forecast: 61.06

Optimistic: 64.29


Bristol-Myers stock forecast for Dec 2025.
Estimated Average Forecasted Bristol-Myers Price: 61.71. Negative monthly dynamics of the instrument is expected with 4.876% volatility is expected.

Pessimistic forecast: 60.25

Optimistic: 63.34



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 126.74 (01.12.2021) 0.77 %
AbbVie Inc.
ABBV 115.91 (01.12.2021) 0.55 %
Aeterna Zentaris Inc.
AEZS 0.45 (01.12.2021) -5.30 %
Allakos Inc.
ALLK 79.6 (01.12.2021) 1.60 %
Allogene Therapeutics, Inc.
ALLO 18.21 (01.12.2021) -1.51 %
Amgen Inc.
AMGN 200.8 (01.12.2021) 0.97 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 17.36 (01.12.2021) -2.96 %
Aurora Cannabis Inc.
ACB 6.01 (01.12.2021) -6.39 %
Becton Dickinson and Company
BDX 241.67 (01.12.2021) 1.91 %
Biogen Inc.
BIIB 228.52 (02.12.2021) -0.43 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 110.13 (01.12.2021) -1.88 %
BioNTech SE
BNTX 334.48 (01.12.2021) -4.91 %
bluebird bio, Inc.
BLUE 10.05 (01.12.2021) -0.59 %
Boston Scientific Corp.
BSX 38.14 (01.12.2021) 0.18 %
Bristol-Myers Squibb Company
BMY 55.41 (02.12.2021) 0.84 %
Canopy Growth Corp.
CGC 9.94 (01.12.2021) -7.19 %
Castle Biosciences, Inc.
CSTL 39.52 (01.12.2021) -4.38 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 249.13 (01.12.2021) 0.44 %
Emergent BioSolutions Inc.
EBS 43.63 (01.12.2021) -1.11 %
Exelixis, Inc.
EXEL 16.48 (02.12.2021) 0.49 %
G1 Therapeutics, Inc.
GTHX 12.51 (01.12.2021) -3.02 %
Gilead Sciences, Inc.
GILD 68.93 (01.12.2021) 0.00 %
GlaxoSmithKline plc
GSK 41.37 (01.12.2021) 0.61 %
GoodRx Holdings, Inc.
GDRX 38.07 (01.12.2021) -4.63 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 66.63 (02.12.2021) 2.57 %
Inovio Pharmaceuticals, Inc.
INO 6.61 (02.12.2021) 0.15 %
Johnson & Johnson
JNJ 158.08 (01.12.2021) 1.38 %
Medtronic plc.
MDT 105.47 (01.12.2021) -1.15 %
Merck & Co., Inc.
MRK 74.44 (01.12.2021) -0.63 %
Moderna, Inc.
MRNA 310.61 (01.12.2021) -11.87 %
Novartis AG
NVS 79.82 (01.12.2021) 0.15 %
Novavax, Inc.
NVAX 192.65 (01.12.2021) -7.66 %
ObsEva SA
OBSV 2.15 (01.12.2021) -4.02 %
OrganiGram Holdings Inc.
OGI 1.95 (02.12.2021) 2.63 %
Pfizer Inc.
PFE 54.68 (01.12.2021) 1.77 %
Regeneron Pharmaceuticals, Inc.
REGN 634 (02.12.2021) 0.54 %
Sanofi
SNY 48.06 (01.12.2021) 1.03 %
Schrodinger, Inc.
SDGR 37.15 (01.12.2021) -5.18 %
Senseonics Holdings, Inc.
SENS 2.85 (01.12.2021) -9.24 %
Sorrento Therapeutics, Inc.
SRNE 5.53 (01.12.2021) -7.21 %
Stryker Corp.
SYK 239.1 (01.12.2021) 1.04 %
Sundial Growers Inc.
SNDL 0.5655 (01.12.2021) -9.05 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.18 (01.12.2021) -0.85 %
Thermo Fisher Scientific Inc.
TMO 626.15 (01.12.2021) -1.06 %
Tilray, Inc.
TLRY 9.27 (01.12.2021) -8.40 %
UnitedHealth Group, Inc.
UNH 444.34 (01.12.2021) 0.03 %
Veeva Systems Inc.
VEEV 272.12 (01.12.2021) -3.70 %
Zomedica Corp.
ZOM 0.375 (01.12.2021) -5.23 %
Zynerba Pharmaceuticals, Inc.
ZYNE 3.31 (01.12.2021) -4.34 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.